Metraipolis › archive › dc_ed1bf695aaaf

Development of a lipoprotein(a)-based model for predicting progression-free survival and grade3/4 adverse events in driver gene negative metastatic lung… — Europe PMC PMID:42112376

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42112376
DOI
10.3389/fimmu.2026.1808231
License (as archived)
solo-consultazione
Archived
2026-11-03T07:35:34.250Z
SHA-256 of the archived text
fa55ca53128fb60680bb732733f15e1336f19926717e8ef0344f1055c745efd8
Stable URL of this page
https://metraipolis.com/documento/dc_ed1bf695aaaf

How to cite

Development of a lipoprotein(a)-based model for predicting progression-free survival and grade3/4 adverse events in driver gene negative metastatic lung… — Europe PMC PMID:42112376 — Europe PMC (en), https://europepmc.org/article/MED/42112376 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ed1bf695aaaf (Metraipolis archive dc_ed1bf695aaaf, sha256 fa55ca53128fb60680bb732733f15e1336f19926717e8ef0344f1055c745efd8)
BibTeX
@misc{dced1bf695aaaf,
  title = {Development of a lipoprotein(a)-based model for predicting progression-free survival and grade3/4 adverse events in driver gene negative metastatic lung… — Europe PMC PMID:42112376},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42112376},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ed1bf695aaaf; sha256 fa55ca53128fb60680bb732733f15e1336f19926717e8ef0344f1055c745efd8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42112376. Agents can read the archived copy with the MCP tool read_document.